Peripheral Vascular Devices Market Analysis, Size, Trends | Global | 2018-2024 | MedSuite

Peripheral Vascular Devices Market Analysis, Size, Trends | Global | 2018-2024 | MedSuite

0

  • Year: 2018
  • Scope: 2014-2024
  • Region: China, Europe, India, Japan, United States
  • Published Date: 04/04/2018
  • Pages: 2958
  • Type: MedSuite

Industry Trends

The peripheral vascular devices market experienced high growth in the mid to late-2000s, but increasing penetration, and strict appropriate usage scrutiny, will lead to a slowdown in growth. Nonetheless, the market is expected to grow at a CAGR in the single-digits throughout the forecast period.

One of the major trends is the ongoing growth in drug-eluting stents. Since its introduction in 2003, drug-eluting stents have experienced a mix of low, high, and stagnant growth, but the trajectory has always been upwards due to consistent cases of stent thrombosis. Recently, the Zilver® PTX® drug-eluting stent by Cook Medical demonstrated positive results in the efficacy of paclitaxel-eluting stents for treatment of Femoropopliteal Disease which has restored excitement around the use of drug-eluting stents in the treatment of peripheral arterial disease as a whole.

Report Regional Coverage

Throughout this research series, iData has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are:

      • United States
      • Europe (15 countries including: Germany, France, U.K., Italy, Spain, Benelux (Belgium, Netherlands and Luxembourg), Scandinavia (Denmark, Finland, Norway and Sweden) Austria, Switzerland and Portugal)
      • Japan
      • India
      • China

The Only Medical Device Market Research With:

Procedure Volume Data & Trends
Unit Sales Growth Analysis
Average Selling Prices
Competitor Shares by Segment & Country
 SKU-Level Research Methods
 The Lowest Acquisition Cost

Highly Detailed Segmentation

While this report suite contains all applicable peripheral vascular device market data, each of the market segments are also available as stand alone MedCore reports. This allows you to get access to only the peripheral vascular market research that you need. You can view all these included reports and segmentation here:

  • Procedure Volumes for Peripheral Vascular Devices – MedPro
  • Peripheral Vascular Stent Market – MedCore
  • PTA Balloon Catheter Market – MedCore
  • Drug Coated Balloon Market – MedCore
  • Chronic Total Occlusion Device Market – MedCore
  • Surgical Graft Market – MedCore
  • Stent Graft Market – MedCore
  • Embolic Protection Device Market – MedCore
  • Peripheral Thrombus Management Device Market – MedCore
  • Inferior Vena Cava Filter & Retrieval Device Market – MedCore
  • Carotid Shunt Market – MedCore
  • Diagnostic and Interventional Guidewire Market – MedCore
  • Introducer Sheath Market – MedCore
  • Vascular Closure Device Market – MedCore
  • Transcatheter Embolization Device Market – MedCore
  • Peripheral IVUS Catheter Market – MedCore

Buying all of these reports together in this suite package will provide you with substantial discounts from the separate prices. Request Pricing to Learn More

Full Segmentation Map for the United States

Data Types Included

    • Unit Sales, Average Selling Prices, Market Value & Growth Trends
    • Procedure Volume Analysis and Trends
    • 10 Year Scope and Forecast Range
    • Market Drivers & Limiters for Each Segment
    • Competitive Analysis with Market Shares for Each Segment
    • Recent Mergers & Acquisitions
    • Disease Overviews and Demographic Information
    • Company Profiles, Product Portfolios and SWOT for Top Competitors

Peripheral Vascular Device Market Share Insights

Medtronic is the peripheral vascular devices market leader for both the United States and European markets. Medtronic offers a wide range of products, and has a strong position in many of the market segments including the stent graft and drug coated balloon markets.

W.L. Gore and Cook Medical also have a significant market share in both of these regions. W.L. Gore is one of the main players in the stent graft market thanks to its VIABAHN covered stents, which have undergone improvements in recent years. Cook Medical also has a solid share in many of the market segments including the inferior vena cava filter & retrieval device market.

All Companies Analyzed in this Study

  • Aachen Resonance GmbH
  • Abbott Laboratories
  • Accession Medical Supplie
  • Acist Medical
  • Advanced Vascular Dynamics
  • ALN International
  • AngioDynamics
  • AngioSlide
  • Aptus Endosystems
  • Argon Medical
  • Arsenal AAA
  • ArtVentive Medical Group
  • Asahi Intec Co.
  • Asahi Intecc USA Inc.
  • AV Medical
  • Avinger
  • B. Braun
  • Baylis Medical
  • Bio2 Medical
  • Biomedicon
  • Biorad Medisys
  • Biosensors International
  • Biotronik
  • Blockade Medical
  • Bolton Medical
  • Boston Scientific
  • BTG
  • C. R. Bard
  • Cardinal Health
  • CardioDex
  • Cardiovascular Systems, Inc.
  • Cardiva
  • Cathex
  • Celenova
  • CID SpA
  • Control Medical Technology
  • Cook Medical
  • Cordis
  • Covidien
  • Creagh Medical
  • DePuy Synthes
  • DirectAccess Medical
  • Edwards LifeSciences
  • Endologix
  • EndoShape
  • Galt Medical
  • Hanaco Medical
  • HemCon Medical Technologies
  • IDev Technologies
  • Incisive Medical
  • Infraredx
  • Integra LifeSciences
  • Invatec
  • Japan Lifeline
  • Jotec Gmbh
  • Kaneka Medical
  • LeMaitre
  • Lombard Medical
  • Maquet
  • Marine Polymer Technologies
  • Medaparat
  • Medikit
  • Medtronic
  • Merit Medical Systems
  • Morris Innovative Inc.
  • Nantec Medical
  • Neotec Medical
  • Nipro
  • Nordion
  • NuCryo Vascular
  • Nuros
  • OptiMed Gmbh
  • Opto Circuits
  • Oscor Inc.
  • Penumbra
  • Pfizer
  • Philips
  • Radius Medical
  • Rafael Medical Technologies
  • Reflow Medical
  • Rex Medical
  • Roxwood Medical
  • Sirtex
  • Sirtex Medical
  • Spectranetics
  • Straub Medical
  • Systems Inc
  • Teleflex Medical
  • Terumo
  • Theragenics
  • Thoratec
  • TriReme Medical
  • TZ Medical
  • Vascular Closure
  • Vascular Flow Technologies
  • Vascular Solutions
  • Vascutek
  • Vasorum
  • Vivasure Medical
  • Volcano Corporation
  • W. L. Gore
  • Zeon Medical

Peripheral Vascular Device Statistics and Procedure Trends

In the United States, peripheral vascular procedure numbers are broken into many areas including plain-old balloon angioplasty, stenting, atherectomy, vascular closure device, and thrombectomy procedures. Of these, the largest amount of procedures are performed in the vascular closure device area, at just under two million performed annually in the United States.

The European market is also broken into many different segments including transcatheter embolization, surgical grafts, the same areas as the United States region that are listed above, and many more. In Europe, the largest amount of procedures are also performed in the vascular closure device area, at over 800,000 annually.

For a Full Table of Contents From Any of the Country Reports in this Global Series, please Contact iData

UNITED STATES TABLE OF CONTENTS I


LIST OF FIGURES XXXVI
LIST OF CHARTS LIII
EXECUTIVE SUMMARY 1
U.S. PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 8
MARKET DEVELOPMENTS 12
PROCEDURE NUMBERS 13
PROCEDURE CODES INVESTIGATED 18
MARKETS INCLUDED 20
KEY REPORT UPDATES 26
VERSION HISTORY 31
RESEARCH METHODOLOGY 32
Step 1: Project Initiation & Team Selection 32
Step 2: Prepare Data Systems and Perform Secondary Research 35
Step 3: Preparation for Interviews & Questionnaire Design 36
Step 4: Performing Primary Research 37
Step 5: Research Analysis: Establishing Baseline Estimates 39
Step 6: Market Forecast and Analysis 40
Step 7: Identify Strategic Opportunities 42
Step 8: Final Review and Market Release 43
Step 9: Customer Feedback and Market Monitoring 44

DISEASE OVERVIEW


2.1 BASIC ANATOMY 45
2.2 DISEASE OVERVIEW 46
2.2.1 Aortic Aneurysms 46
2.2.2 Atherosclerosis 47
2.2.3 Peripheral Arterial Disease (PAD) 47
2.2.4 Deep Vein Thrombosis (DVT) 48
2.2.5 Pulmonary Embolism (PE) 49
2.3 PATIENT DEMOGRAPHICS 51
2.3.1 Aortic Aneurysms 51
2.3.2 Atherosclerosis 52
2.3.3 Peripheral Arterial Disease (PAD) 52
2.3.4 Deep Vein Thrombosis (DVT) 52
2.3.5 Pulmonary Embolism (PE) 53

PRODUCT ASSESSMENT


3.1 PRODUCT ASSESSMENT 54
3.1.1 Peripheral Vascular Stent 54
3.1.2 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter 57
3.1.3 Drug-Coated Balloon 61
3.1.4 Atherectomy Device 63
3.1.5 Chronic Total Occlusion (CTO) Device 65
3.1.6 Surgical Graft 67
3.1.7 Stent Graft 70
3.1.8 Embolic Protection Device 72
3.1.9 Peripheral Thrombus Management Device 74
3.1.10 Inferior Vena Cava Filter 77
3.1.11 Carotid Shunt 79
3.1.12 Diagnostic and Interventional Catheters 81
3.1.13 Diagnostic and Interventional Guidewires 84
3.1.14 Introducer Sheath 87
3.1.15 Vascular Closure Devices (VCD) 90
3.1.16 Transcatheter Embolization Devices 93
3.1.17 Peripheral IVUS Catheter 96
3.2 REGULATORY ISSUES AND RECALLS 98
3.2.1 Abbott Laboratories 98
3.2.1.1 Carotid Shunt 98
3.2.1.2 Vascular Closure Device 98
3.2.2 Argon Medical 99
3.2.2.1 Introducer Sheaths 99
3.2.3 Arrow International 100
3.2.3.1 Introducer Sheaths 100
3.2.4 Atrium Medical 102
3.2.4.1 Peripheral Vascular Stent 102
3.2.5 Bard Peripheral Vascular 102
3.2.5.1 Inferior Vena Cava Filter 102
3.2.5.2 Introducer Sheaths 103
3.2.5.3 Stent Graft 103
3.2.6 Boston Scientific 104
3.2.6.1 Atherectomy Devices 104
3.2.6.2 Diagnostic and Interventional Catheter 105
3.2.6.3 Introducer Sheaths 107
3.2.6.4 Peripheral Thrombus Management Device 108
3.2.7 Cardinal Health 109
3.2.7.1 Vascular Closure Device (VCD) 109
3.2.8 Cardiovascular System (C.S.I.) 110
3.2.8.1 Atherectomy Devices 110
3.2.9 Cook Medical 112
3.2.9.1 Diagnostic and Interventional Catheter 112
3.2.9.2 Introducer Sheath 112
3.2.9.3 Peripheral Vascular Stents 113
3.2.9.4 Stent Graft 113
3.2.10 Cordis 114
3.2.10.1 Inferior Vena Cava Filter 114
3.2.10.2 Peripheral Stents 114
3.2.11 Endologix 115
3.2.11.1 Stent Graft 115
3.2.12 Edwards Lifesciences 116
3.2.12.1 Chronic Total Occlusion Devices 116
3.2.13 Medtronic 117
3.2.13.1 Carotid Shunt 117
3.2.13.2 Diagnostic and Interventional Catheter 117
3.2.13.3 Percutaneous transluminal angioplasty (PTA) Balloon Catheter 118
3.2.13.4 Peripheral Stents 119
3.2.13.5 Stent Graft 119
3.2.13.6 Transcatheter Embolization Devices 120
3.2.14 Spectranetics 121
3.2.14.1 Atherectomy Devices 121
3.2.14.2 Chronic Total Occlusion Devices 122
3.2.15 Terumo 123
3.2.15.1 Introducer Sheaths 123
3.2.16 Other companies 124
3.2.16.1 Atherectomy 124
3.2.16.2 Introducer Sheaths 124
3.2.16.3 Percutaneous transluminal angioplasty (PTA) Balloon Catheter 124
3.2.16.4 Peripheral IVUS Catheters 125
3.2.16.5 Stent Graft 125
3.2.16.6 Vascular Closure Device (VCD) 126
3.3 CLINICAL TRIALS 127
3.3.1 Abbott Laboratories 127
3.3.1.1 Peripheral Vascular Stent 127
3.3.1.2 Other Peripheral Vascular Related Studies 129
3.3.2 B. Braun 130
3.3.2.1 Diagnostic and Interventional Catheters 130
3.3.2.2 Peripheral Vascular Stent 130
3.3.3 Boston Scientific 131
3.3.3.1 Atherectomy Devices 131
3.3.3.2 Drug Coated Balloons 132
3.3.3.3 Peripheral Vascular Stent 134
3.3.3.4 Other Peripheral Vascular Related Studies 135
3.3.4 C.R. Bard 136
3.3.4.1 Diagnostic and Interventional Catheters 136
3.3.4.2 Drug Coated Balloons 136
3.3.4.3 Other Peripheral Vascular Related Studies 138
3.3.5 Cardinal Health 139
3.3.5.1 Other Peripheral Vascular Related Studies 139
3.3.6 Cook Medical 140
3.3.6.1 Drug Eluting Stent 140
3.3.6.2 Inferior Vena Cava Filter 142
3.3.6.3 Peripheral Vascular Stent 142
3.3.7 Cordis 144
3.3.7.1 Peripheral Vascular Stent 144
3.3.8 Medtronic 145
3.3.8.1 Atherectomy Devices 145
3.3.8.2 Drug Coated Balloon 145
3.3.8.3 Other Peripheral Vascular Related Studies 151
3.3.9 Philips Volcano 152
3.3.9.1 Peripheral IVUS Catheter 152
3.3.10 Spectranetics 153
3.3.10.1 Drug-Coated Balloons 153
3.3.11 Surmodics 156
3.3.11.1 Drug-Coated Balloons 156
3.3.12 Terumo 157
3.3.12.1 Drug-Coated Balloons 157
3.3.12.2 Peripheral Vascular Stent 157
3.3.13 W.L. Gore 158
3.3.13.1 Peripheral Vascular Stent 158
3.3.13.2 Stent Graft 159
3.3.14 Other companies 160
3.3.14.1 Carotid Shunt / Endarterectomy 160
3.3.14.2 Drug Coated Balloon 161
3.3.14.3 Peripheral Vascular Stent 166
3.3.14.4 Other Peripheral Vascular Related Studies 169

U.S. PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW


4.1 INTRODUCTION 170
4.1.1 Atherosclerosis 170
4.1.2 Peripheral Arterial Disease (PAD) 170
4.2 MARKET OVERVIEW 172
4.3 TREND ANALYSIS BY SEGMENT 178
4.4 DRIVERS AND LIMITERS 183
4.4.1 Market Drivers 183
4.4.2 Market Limiters 186
4.5 COMPETITIVE MARKET SHARE ANALYSIS 189
4.6 MERGERS AND ACQUISITIONS 201
4.7 COMPANY PROFILES 205
4.7.1 Abbott Laboratories 205
4.7.2 Boston Scientific 208
4.7.3 BTG 211
4.7.4 C.R. Bard 212
4.7.5 Cardinal Health 213
4.7.6 Cook Medical 215
4.7.7 Medtronic 216
4.7.8 Teleflex 219
4.7.9 Terumo Interventional System (TIS) 222
4.7.10 W.L. Gore 224
4.8 SWOT ANALYSIS 225
4.8.1 Abbott Laboratories 226
4.8.1.1 St. Jude Medical (Abbott Laboratories) 228
4.8.2 Boston Scientific 229
4.8.3 BTG 230
4.8.4 C.R. Bard 231
4.8.5 Cardinal Health 232
4.8.5.1 Cordis (Cardinal Health) 233
4.8.6 Cook Medical 234
4.8.7 Medtronic 235
4.8.8 Teleflex 237
4.8.8.1 Vascular Solutions (Teleflex) 239
4.8.9 Terumo Interventional System (TIS) 240
4.8.10 W.L. Gore 242

PROCEDURE NUMBERS


5.1 INTRODUCTION 243
5.2 PROCEDURES 245
5.2.1 Total Peripheral Vascular Procedures 245
5.2.2 Peripheral Vascular Stent Procedures 251
5.2.2.1 Stenting Procedures by Stent Type 253
Bare-Metal Stent Procedures 255
Covered Stent Procedures 268
Drug-Eluting Stent Procedures 270
5.2.3 PTA Balloon Catheter Procedures 273
5.2.4 Drug Coated Balloon Procedures 276
5.2.4.1 Drug Coated Balloon Procedures by Indication 277
5.2.4.2 Drug Coated Balloon Procedures by Setting 279
5.2.5 Atherectomy Procedures 280
5.2.5.1 Atherectomy Procedures by Device Type 282
5.2.5.2 Atherectomy Procedures by Indication 283
Fem-Popliteal Artery Atherectomy Procedures by Type 286
Infra-Popliteal Artery Atherectomy Procedures by Type 287
5.2.5.3 Atherectomy Procedures by Setting 288
5.2.6 CTO Device Procedures 289
5.2.6.1 CTO Device Procedures by Type 290
5.2.7 Surgical Graft Procedures 291
5.2.7.1 Surgical Graft Procedures by Graft Material 292
5.2.7.2 Surgical Graft Procedures by Indication 294
Lower Limb Surgical Graft Procedures by Anatomy 296
Aorta Repair Surgical Graft Procedures by Anatomy 297
5.2.8 Stent Graft Procedures 298
5.2.8.1 Endovascular Stent Graft Procedures by Type 299
5.2.8.2 EVAR Procedures 301
EVAR Procedures by Anatomy 301
EVAR Procedures by Complexity 302
EVAR Procedures by Fenestration 303
EVAR Procedures by Anesthesia Type 304
EVAR Procedures by Gender 305
5.2.8.3 TEVAR Procedures 306
TEVAR Procedures by Indication 306
TEVAR Procedures by Gender 307
5.2.9 Embolic Protection Procedures 308
5.2.9.1 Embolic Protection Procedures by Type 309
5.2.10 Peripheral Thrombus Management Procedures 311
5.2.10.1 Peripheral Thrombus Management Procedures by Procedure Type 312
5.2.10.2 Peripheral Thrombus Management Procedures by Indication 314
5.2.11 Inferior Vena Cava Filter Procedures 315
5.2.11.1 Inferior Vena Cava Filter Procedures by Procedure Type 317
5.2.12 Carotid Intervention Procedures 319
5.2.12.1 Carotid Interventions by Procedure Type 321
5.2.13 Vascular Closure Procedures 323
5.2.13.1 Vascular Closure Procedures by Device Type 325
Invasive Vascular Closure Procedures by Device Size 327
5.2.13.2 Vascular Closure Procedures by Approach 330
5.2.14 Transcatheter Embolization Procedures 332
5.2.14.1 Transcatheter Embolization Procedures by Device Type 333
Transcatheter Particle Embolization Procedures by Device Type 336
Transcatheter Coil Embolization Procedures by Device Type 338
5.2.15 Peripheral IVUS Procedures 339
5.2.15.1 Peripheral IVUS Procedures by Indication 340

PERIPHERAL VASCULAR STENT MARKET


6.1 INTRODUCTION 342
6.1.1 Off-Label Use 343
6.1.2 Covered Stents 343
6.1.3 Drug-Eluting Peripheral Vascular Stents 344
6.1.4 Infrapopliteal Stenting 345
6.1.5 Stent Length 345
6.1.6 General Information 346
6.2 MARKET OVERVIEW 347
6.3 MARKET ANALYSIS AND FORECAST 351
6.3.1 Bare-Metal Stent Market 351
6.3.1.1 Total Bare-Metal Stent Market 352
6.3.1.2 Bare-Metal Stent Market by Indication 354
Bare-Metal Carotid Stent Market 358
Bare-Metal Renal Stent Market 360
Bare-Metal Iliac Stent Market 362
Bare-Metal Fem-Popliteal Stent Market 364
Bare-Metal Infra-Popliteal Stent Market 366
6.3.1.3 Bare-Metal Stent Market by Delivery Platform 368
Self-Expanding Bare-Metal Stent Market 370
Balloon Expanding Bare-Metal Stent Market 372
6.3.2 Covered Stent Market 374
6.3.2.1 Iliac Covered Stent Market 376
6.3.2.2 Fem-Pop Covered Stent Market 378
6.3.2.3 AV Access Covered Stent Market 380
6.3.3 Total Drug-Eluting Stent Market 382
6.3.3.1 SFA Drug-Eluting Stent Market 385
6.3.3.2 Infra-Popliteal Drug-Eluting Stent Market 387
6.4 UNIT ANALYSIS 389
6.4.1 Units Sold by Stent Length 389
6.4.1.1 Bare-Metal Carotid Stent Units 391
6.4.1.2 Bare-Metal Renal Stent Units 393
6.4.1.3 Bare-Metal Iliac Stent Units 395
6.4.1.4 Bare-Metal Fem-Popliteal Stent Units 397
6.5 DRIVERS AND LIMITERS 399
6.5.1 Market Drivers 399
6.5.2 Market Limiters 400
6.6 COMPETITIVE MARKET SHARE ANALYSIS 403
6.6.1 Total Peripheral Vascular Stent Market 403
6.6.2 Bare-Metal Stent Market by Indication 408
6.6.2.1 Iliac 408
6.6.2.2 Carotid 408
6.6.2.3 Renal 409
6.6.2.4 Femoral-Popliteal 410
6.6.2.5 Infra-Popliteal 410
6.6.3 Bare-Metal Stent Market by Delivery Platform 412
6.6.4 Drug-Eluting Stent Market by Indication 414
6.6.4.1 SFA Drug-Eluting Stent Market 414
6.6.4.2 Infra-Popliteal Drug-Eluting Stent Market 414

PTA BALLOON CATHETER MARKET


7.1 INTRODUCTION 417
7.1.1 PTA Balloon Catheter Definitions 417
7.2 MARKET OVERVIEW 419
7.3 MARKET ANALYSIS AND FORECAST 423
7.3.1 Total PTA Balloon Catheter Market 423
7.3.2 Total Standard PTA Balloon Catheter Market 426
7.3.2.1 Hospital Standard PTA Balloon Catheter Market 429
7.3.2.2 Office-Based Lab Standard PTA Balloon Catheter Market 431
7.3.3 High-Pressure PTA Balloon Catheter Market 433
7.3.4 Large PTA Balloon Catheter Market 435
7.3.5 Small PTA Balloon Catheter Market 437
7.3.5.1 0.014” Small PTA Balloon Catheter Market 440
7.3.5.2 0.018” Small PTA Balloon Catheter Market 442
7.3.6 Specialty PTA Balloon Catheter Market 444
7.4 UNIT ANALYSIS 447
7.4.1 Units Sold by Application 447
7.5 DRIVERS AND LIMITERS 449
7.5.1 Market Drivers 449
7.5.2 Market Limiters 450
7.6 COMPETITIVE ANALYSIS 452
7.6.1 Standard PTA Balloon Catheter Market 452
7.6.1.1 Medtronic 452
7.6.1.2 C. R. Bard 452
7.6.1.3 Cardinal Health 452
7.6.1.4 Abbott Vascular 453
7.6.1.5 Cook Medical 453
7.6.1.6 AngioDynamics 453
7.6.2 High-Pressure PTA Balloon Catheter Market 453
7.6.2.1 C. R. Bard 453
7.6.2.2 Boston Scientific 453
7.6.2.3 Cardinal Health 454
7.6.2.4 Abbott Vascular 454
7.6.2.5 Medtronic 454
7.6.3 Large PTA Balloon Catheter Market 454
7.6.3.1 C. R. Bard 454
7.6.3.2 Boston Scientific 454
7.6.3.3 Cardinal Health 455
7.6.3.4 B. Braun 455
7.6.4 Small PTA Balloon Catheter Market 455
7.6.4.1 Boston Scientific 455
7.6.4.2 Cardinal Health 455
7.6.4.3 Abbott Vascular 455
7.6.4.4 Medtronic 456
7.6.4.5 Cook Medical 456
7.6.4.6 C. R. Bard 456
7.6.4.7 Other Notable Competitors 456
7.6.5 Specialty PTA Balloon Catheter Market 456
7.6.5.1 Philips 456
7.6.5.2 Boston Scientific 457
7.6.5.3 Medtronic 457
7.6.5.4 C. R. Bard 457
7.6.5.5 Other Notable Competitors 458

DRUG COATED BALLOON MARKET


8.1 INTRODUCTION 461
8.2 MARKET ANALYSIS AND FORECAST 463
8.3 UNIT ANALYSIS 466
8.3.1 Units Sold by Sheath Size 467
8.3.2 Units Sold by Balloon Diameter 469
8.3.3 Units Sold by Balloon Length 471
8.3.4 Units Sold by Shaft Length 473
8.3.5 Units Sold by Rated Burst Pressure 475
8.4 DRIVERS AND LIMITERS 477
8.4.1 Market Drivers 477
8.4.2 Market Limiters 478
8.5 COMPETITIVE MARKET SHARE ANALYSIS 480

ATHERECTOMY DEVICE MARKET


9.1 INTRODUCTION 483
9.2 MARKET OVERVIEW 485
9.2.1 Atherectomy Device Market Overview by Technology 485
9.2.2 Atherectomy Disposables Market Overview by Setting 489
9.3 MARKET ANALYSIS AND FORECAST 492
9.3.1 Atherectomy Device Market by Technology 493
9.3.1.1 Total Laser Atherectomy Device Market 493
Laser Atherectomy Console Market 495
Laser Atherectomy Disposable Market 499
9.3.1.2 Mechanical Atherectomy Disposable Market 501
9.3.2 Atherectomy Device Market by Setting 503
9.3.2.1 Hospital Market 503
9.3.2.2 Office-Based Lab Market 505
9.3.3 Atherectomy Device Market by Device Type 507
9.3.3.1 Atherectomy Disposable Market 508
9.4 DRIVERS AND LIMITERS 510
9.4.1 Market Drivers 510
9.4.2 Market Limiters 511
9.5 COMPETITIVE MARKET SHARE ANALYSIS 513

CTO DEVICE MARKET


10.1 INTRODUCTION 518
10.2 MARKET OVERVIEW 519
10.3 MARKET ANALYSIS AND FORECAST 522
10.3.1 Total CTO Device Market 522
10.3.2 Re-Entry Device Market 525
10.3.3 Re-Canalization Device Market 528
10.4 DRIVERS AND LIMITERS 531
10.4.1 Market Drivers 531
10.4.2 Market Limiters 531
10.5 COMPETITIVE MARKET SHARE ANALYSIS 533

SURGICAL GRAFT MARKET


11.1 INTRODUCTION 537
11.2 MARKET OVERVIEW 539
11.2.1 Surgical Graft Market Overview by Indication 539
11.2.2 Surgical Graft Market Overview by Material 543
11.3 MARKET ANALYSIS AND FORECAST 546
11.3.1 Total Surgical Graft Market 546
11.3.2 Surgical Graft Market by Indication 548
11.3.2.1 Total Lower Limb Surgical Graft Market 548
Above-the-Knee Surgical Graft Market 551
Below-the-Knee Surgical Graft Market 553
11.3.2.2 Total Aorta Repair Surgical Graft Market 555
Abdominal Aortic Aneurysm Surgical Graft Market 558
Thoracic Aortic Aneurysm Surgical Graft Market 560
11.3.2.3 Extra-Anatomical Bypass Surgical Graft Market 562
11.3.3 Surgical Graft Market by Material 564
11.3.3.1 Polyester Surgical Graft Market 564
11.3.3.2 ePTFE Surgical Graft Market 566
11.4 DRIVERS AND LIMITERS 568
11.4.1 Market Drivers 568
11.4.2 Market Limiters 569
11.5 COMPETITIVE MARKET SHARE ANALYSIS 571

STENT GRAFT MARKET


12.1 INTRODUCTION 575
12.2 MARKET OVERVIEW 577
12.3 MARKET ANALYSIS AND FORECAST 580
12.3.1 Total Stent Graft Market 580
12.3.2 Total AAA Stent Graft Market 582
12.3.2.1 Bifurcated Main Body Graft Market 586
12.3.2.2 Contralateral/Ipsilateral Iliac Leg/Limb Market 588
12.3.2.3 Aorto-uni-iliac (AUI) Stent Graft Market 590
12.3.2.4 Iliac Extension Market 592
12.3.2.5 Aortic Extension Market 594
12.3.3 Total Fenestrated Stent Graft Market 596
12.3.3.1 Fenestrated Distal Bifurcated Graft Market 599
12.3.3.2 Fenestrated Proximal Body Graft Market 601
12.3.4 TAA Stent Graft Market 603
12.4 DRIVERS AND LIMITERS 606
12.4.1 Market Drivers 606
12.4.2 Market Limiters 608
12.5 COMPETITIVE MARKET SHARE ANALYSIS 609

EMBOLIC PROTECTION DEVICE MARKET


13.1 INTRODUCTION 615
13.1.1 New Applications 615
13.1.2 Protection Mechanism 616
13.1.2.1 Filter Devices 616
13.1.2.2 Balloon Occlusion Systems 616
13.1.2.3 Flow Redirection 617
13.2 MARKET OVERVIEW 618
13.3 MARKET ANALYSIS AND FORECAST 621
13.3.1 Total Embolic Protection Device Market 621
13.3.2 Carotid EPD Market 623
13.3.3 Total Alternative EPD Market 626
13.3.3.1 Renal EPD Market 630
13.3.3.2 Lower Limb EPD Market 632
13.4 DRIVERS AND LIMITERS 634
13.4.1 Market Drivers 634
13.4.2 Market Limiters 635
13.5 COMPETITIVE MARKET SHARE ANALYSIS 637

PERIPHERAL THROMBUS MANAGEMENT DEVICE MARKET


14.1 INTRODUCTION 640
14.1.1 AV Access Thrombectomy Devices 640
14.1.2 Other Peripheral Applications of Thrombectomy Devices 640
14.2 MARKET OVERVIEW 642
14.2.1 Peripheral Thrombus Management Device Market Overview by Device Type 642
14.2.2 Peripheral Thrombus Management Device Market Overview by Indication 646
14.3 MARKET ANALYSIS AND FORECAST 650
14.3.1 Total Peripheral Thrombus Management Device Market 650
14.3.2 Peripheral Thrombus Management Device Market by Device Type 652
14.3.2.1 Traditional Thrombectomy Device Market 652
14.3.2.2 Pharmacomechanical Thrombectomy Device Market 655
14.3.2.3 Catheter Directed Thrombolysis Device Market 658
14.3.3 Peripheral Thrombus Management Device Market by Indication 660
14.3.3.1 AV Access Thrombus Management Device Market 660
14.3.3.2 Arterial & Venous Thrombus Management Device Market 662
14.4 DRIVERS AND LIMITERS 665
14.4.1 Market Drivers 665
14.4.2 Market Limiters 666
14.5 COMPETITIVE MARKET SHARE ANALYSIS 668

INFERIOR VENA CAVA FILTER & RETRIEVAL DEVICE MARKET


15.1 INTRODUCTION 673
15.2 MARKET OVERVIEW 675
15.3 MARKET ANALYSIS AND FORECAST 678
15.3.1 Total Inferior Vena Cava Filter Market 678
15.3.1.1 Retrievable IVCF Market 680
15.3.1.2 Permanent IVCF Market 682
15.3.2 Inferior Vena Cava Filter Retrieval Device Market 684
15.4 DRIVERS AND LIMITERS 686
15.4.1 Market Drivers 686
15.4.2 Market Limiters 687
15.5 COMPETITIVE MARKET SHARE ANALYSIS 689

CAROTID SHUNT MARKET


16.1 INTRODUCTION 693
16.2 MARKET ANALYSIS AND FORECAST 694
16.3 DRIVERS AND LIMITERS 696
16.3.1 Market Drivers 696
16.3.2 Market Limiters 696
16.4 COMPETITIVE MARKET SHARE ANALYSIS 698

DIAGNOSTIC & INTERVENTIONAL CATHETER MARKET


17.1 INTRODUCTION 700
17.2 MARKET OVERVIEW 701
17.3 MARKET ANALYSIS AND FORECAST 704
17.3.1 Total Diagnostic & Interventional Catheter Market 704
17.3.2 Total Diagnostic Catheter Market 706
17.3.2.1 Standard Diagnostic Catheter Market 710
17.3.2.2 Hydrophilic Diagnostic Catheter Market 712
17.3.3 Support Catheter Market 714
17.4 DRIVERS AND LIMITERS 717
17.4.1 Market Drivers 717
17.4.2 Market Limiters 718
17.5 COMPETITIVE MARKET SHARE ANALYSIS 719

DIAGNOSTIC & INTERVENTIONAL GUIDEWIRE MARKET


18.1 INTRODUCTION 724
18.2 MARKET OVERVIEW 725
18.3 MARKET ANALYSIS AND FORECAST 728
18.3.1 Total Diagnostic & Interventional Guidewire Market 728
18.3.2 Standard Guidewire Market 730
18.3.3 Hydrophilic Guidewire Market 732
18.4 DRIVERS AND LIMITERS 734
18.4.1 Market Drivers 734
18.4.2 Market Limiters 734
18.5 COMPETITIVE MARKET SHARE ANALYSIS 736

INTRODUCER SHEATH MARKET


19.1 INTRODUCTION 739
19.2 MARKET OVERVIEW 740
19.3 MARKET ANALYSIS AND FORECAST 743
19.3.1 Total Introducer Sheath Market 743
19.3.2 Standard Introducer Sheath Market 745
19.3.3 Guiding Introducer Sheath Market 747
19.4 DRIVERS AND LIMITERS 749
19.4.1 Market Drivers 749
19.4.2 Market Limiters 749
19.5 COMPETITIVE MARKET SHARE ANALYSIS 751

VASCULAR CLOSURE DEVICE MARKET


20.1 INTRODUCTION 755
20.2 MARKET OVERVIEW 757
20.2.1 Vascular Closure Device Market Overview by Device Type 757
20.2.2 Vascular Closure Device Market Overview by Approach 760
20.3 MARKET ANALYSIS AND FORECAST 763
20.3.1 Total Vascular Closure Device Market 763
20.3.2 Vascular Closure Device Market by Device Type 765
20.3.2.1 Total Invasive VCD Market 765
Small-Bore Invasive VCD Market 768
Large-Bore Invasive VCD Market 770
20.3.2.2 Non-Invasive VCD Market 773
20.3.3 Vascular Closure Device Market by Approach 775
20.3.3.1 Femoral VCD Market 775
20.3.3.2 Radial VCD Market 777
20.4 DRIVERS AND LIMITERS 779
20.4.1 Market Drivers 779
20.4.2 Market Limiters 780
20.5 COMPETITIVE MARKET SHARE ANALYSIS 782
20.5.1 Leading Competitors 782
20.5.2 Emerging Competitors 784

TRANSCATHETER EMBOLIZATION DEVICE MARKET


21.1 INTRODUCTION 789
21.1.1 Particle Embolics 790
21.1.2 Coil Embolics 790
21.1.3 Liquid Embolics 790
21.1.4 Vascular Plugs 791
21.2 MARKET OVERVIEW 793
21.3 MARKET ANALYSIS AND FORECAST 796
21.3.1 Total Transcatheter Embolization Device Market 796
21.3.2 Total Embolization Particle Market 798
21.3.2.1 PVA Particle Market 802
21.3.2.2 Microsphere Market 804
21.3.2.3 Drug-Eluting Particle Market 806
21.3.2.4 Radioactive Particle Market 808
21.3.3 Total Embolization Coil Market 810
21.3.3.1 Pushable Coil Market 814
21.3.3.2 Detachable Coil Market 816
21.3.4 Embolization Liquid Market 818
21.3.5 Embolization Plug Market 820
21.4 DRIVERS AND LIMITERS 823
21.4.1 Market Drivers 823
21.4.2 Market Limiters 824
21.5 COMPETITIVE MARKET SHARE ANALYSIS 825

PERIPHERAL IVUS CATHETER MARKET


22.1 INTRODUCTION 833
22.2 MARKET ANALYSIS AND FORECAST 834
22.3 DRIVERS AND LIMITERS 837
22.3.1 Market Drivers 837
22.3.2 Market Limiters 837
22.4 COMPETITIVE MARKET SHARE ANALYSIS 839

ABBREVIATIONS


APPENDIX: COMPANY PRESS RELEASES

One of the the most accurate methods of market research in the medical device industry is to analyze the procedure volumes and trends. Through this study on peripheral vascular devices, iData Research has performed an analysis on the following procedure segments in order to increase the accuracy of our market sizing, and provide you with the volume of procedures over a 10 year range. While the below market segmentation map is representative of the United States, procedure volume data is also provided for the other regions within this complete series.  

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link
close-link